Ads
related to: ortho evra weight gain productsebay.com has been visited by 1M+ users in the past month
Search results
Results from the WOW.Com Content Network
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.
The 20 cm 2 Evra contraceptive patch contains 600 μg ethinylestradiol and 6000 μg norelgestromin. [8] The Ortho Evra contraceptive patch and the Evra contraceptive patch are both intended to gradually release into the systemic circulation approximately 20 μg/day of ethinylestradiol and 150 μg/day of norelgestromin. [5] [8]
Norelgestromin is available only as a transdermal contraceptive patch in combination with ethinyl estradiol. [6] The Ortho Evra patch is a 20 cm 2, once-weekly adhesive that contains 6.0 mg norelgestromin and 0.6 mg ethinyl estradiol and delivers 200 μg/day norelgestromin and 35 μg/day ethinyl estradiol.
Contraceptive patches (marketed as Ortho Evra or Evra) and; Testosterone CIII patches for both men (Androderm) and women (Intrinsa). Nitroglycerin patches are sometimes prescribed for the treatment of angina in lieu of sublingual pills. Transdermal scopolamine is commonly used as a treatment for motion sickness. [8]
The first birth control patch, "Ortho Evra" was first introduced in 2002. [51] In 2014, a generic version of Ortho Evra was released and called "Xulane". [ 52 ] In 2020, the FDA approved Twirla, a low-dose transdermal combined hormonal contraceptive.
In 1999, Johnson & Johnson had signed a contract with a company called Excerpta Medica. Its specialty was medical marketing. Its sub-specialty was producing ghostwritten, data-filled studies on the efficacy and safety of a client’s drugs, finding the right academic scholars to be listed as the authors and then placing the articles in prestigious academic journals.
Ads
related to: ortho evra weight gain productsebay.com has been visited by 1M+ users in the past month